Results 51 to 60 of about 44,983 (288)

Primary Angiosarcoma of the Spleen: An Oncological Enigma

open access: yesCase Reports in Oncological Medicine, 2014
Introduction. Primary splenic angiosarcoma is an extremely unusual neoplasm originating from sinusoidal vascular endothelium. Surgical extirpation is the mainstay of treatment of this highly malignant disease. Case Presentation.
Myoteri Despoina   +5 more
doaj   +1 more source

Lung adenocarcinoma and splenic histiocytic sarcoma in an African pygmy hedgehog (Atelerix albiventris)

open access: yesBrazilian Journal of Veterinary Pathology, 2023
The African pygmy hedgehog is increasingly being kept as a pet, and studies regarding the primary diseases that affect this species are essential for advancing medicine in these animals.
Isabela Coelho Zanoti   +4 more
doaj   +1 more source

Ratio between splenic and circulating CD33+CD14HLA-DR+ immature myeloid cells. [PDF]

open access: yes, 2013
Ref. = reference group made of patients with chronic pancreatitis and of patients with splenic non-neoplastic lesions; BPNs = Borderline pancreatic neoplasms; PDAC = Ductal adenocarcinoma; NETs = Neuroendocrine tumors.
Cosimo Sperti (287027)   +23 more
core   +1 more source

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling

open access: yesFEBS Open Bio, EarlyView.
Pharmacological inhibition of PERK in a DEN‐induced mouse model of liver cancer does not reduce tumor burden but alters cellular stress signaling. Despite blocking PERK activity, downstream stress responses, including CHOP expression, remain active, suggesting compensatory mechanisms within the unfolded protein response that may influence tumor ...
Ada Lerma‐Clavero   +5 more
wiley   +1 more source

Rare Coincidence of Gastric Cancer and Large Myofibroblastic Tumor of The Spleen

open access: yesActa Medica Bulgarica
Although its incidence has been decreasing during the last decades, gastric cancer remains a common disease and a global health problem. Conversely, inflammatory myofibroblastic tumors, especially the splenic ones, are extremely rare neoplasms.
Arabadzhieva E.
doaj   +1 more source

Isolated splenic sarcoidosis: A case report

open access: yesAnales del Sistema Sanitario de Navarra
Isolated splenic sarcoidosis is a rare entity, but clinicians should consider it in patients with compatible clinical features. Its diagnosis is challenging due to the broad differential diagnosis, which includes hematologic and splenic neoplasms ...
Coro Velasco Gametxogoikoetxea   +2 more
doaj   +1 more source

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

open access: yesFEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin   +12 more
wiley   +1 more source

Splenic lymphoid change in abdominal neoplasmic patients: analysis of 121 cases [PDF]

open access: yesJournal of Korean Medical Science, 1994
Because the spleen is likely to play a specific role in immunity, we have tried to observe the influence of the abdominal neoplasms on splenic lymphoid tissue as well as the distribution and localization of immunoregulatory cells with a special attention to the marginal zone, using splenectomy specimens in the various kinds of 121 abdominal neoplasm ...
H J, Cho, I H, Ko
openaire   +2 more sources

PRIMARY SPLENIC DIFFUSE LARGE B-CELL LYMPHOMA WITH CD30 EXPRESSION: A RARE CASE REPORT

open access: yesTurkish Medical Student Journal
Primary splenic diffuse large B-cell lymphoma represents a very uncommon manifestation within the spectrum of non-Hodgkin lymphomas, comprising approximately 1% of the total caseload.
Beyza Öztürk   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy